Glyburide And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 57237-024

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glyburide And Metformin Hydrochloride (NDC 57237-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (1.25 mg/250 mg (100 Tablets Bottle))

Package Label-principal Display Panel (1.25 mg/250 mg (100 Tablets Bottle))
This text is a description of a medication called FRising. It is a combination of Glyburide and Metformin Hydrochloride USP used for treating diabetes. It is recommended to be stored at a temperature between 20°C to 25°C. The packaging is a container with a child-resistant closure, and it has 100 tablets. It is distributed by a company called Rising Health LLC. The text also includes some product codes and manufacturing information.*
FDA Label Image

Package Label-principal Display Panel (2.5 mg/500 mg (100 Tablets Bottle))

Package Label-principal Display Panel (2.5 mg/500 mg (100 Tablets Bottle))
The Rising NDC 57237-024-01 medicine contains a combination of glyburide and metformin hydrochloride tablets. Each film-coated tablet contains 2.5 mg/500 mg of glyburide and metformin hydrochloride USP. The medicine's usual dosage is mentioned in the package insert which was revised on 122017. The medicine should be stored in a light-resistant container with a child-resistant closure. The medicine is distributed by Rising Health, LLC located in New Jersey. The code TS/DRUGS/19/1983 is associated with this medication. The given code is the Over Printing Zone Coding Area of size 45x 15 mm. The temperature for storing the medicine should be between 20° to 25°C and excursions are permitted from 15° to 30°C.*
FDA Label Image

Package Label-principal Display Panel (5 mg/500 mg (100 Tablets Bottle))

Package Label-principal Display Panel (5 mg/500 mg (100 Tablets Bottle))
Rising NpC 57237-025-01 is a medication consisting of the combination of Glyburide and Metformin Hydrochloride in USP film-coated tablets, with each tablet containing 5mg/500mg of the active ingredients. The usual dosage can be found in the package insert. The tablets should be stored in the range of 20°C to 25°C, with excursions permitted between 15°C to 30°C. The medication is dispensed with a child-resistant container. Rising Health, LLC, based in Saddle Brook, NJ, distributes this medication. There is also a printing zone within the label.*
FDA Label Image

Glyburide Chemical Structure (Glymet Str1)

Glyburide Chemical Structure (Glymet Str1)
FDA Label Image

Metformin Hydrochloride Chemical Structure (Glymet Str2)

Metformin Hydrochloride Chemical Structure (Glymet Str2)
The text seems to be a chemical compound formula indicating the Metformin Hydrochloride molecules. The symbol b (=) might indicate a bond or a link between the atoms. The other texts appear to be abbreviations of chemical elements such as NH (Nitrogen and Hydrogen), T, and HCI (Hydrochloric acid). Therefore, this description could be interpreted as a formula for the Metformin Hydrochloride compound.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.